1. Home
  2. MNDY vs BIO Comparison

MNDY vs BIO Comparison

Compare MNDY & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo monday.com Ltd.

MNDY

monday.com Ltd.

HOLD

Current Price

$75.14

Market Cap

7.4B

Sector

Technology

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$268.16

Market Cap

7.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNDY
BIO
Founded
2012
1952
Country
Israel
United States
Employees
N/A
7450
Industry
Computer Software: Prepackaged Software
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.4B
7.1B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
MNDY
BIO
Price
$75.14
$268.16
Analyst Decision
Buy
Strong Buy
Analyst Count
25
4
Target Price
$174.92
$358.50
AVG Volume (30 Days)
2.0M
248.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$20.70
$2.51
Revenue Next Year
$16.48
$3.17
P/E Ratio
$34.38
$9.72
Revenue Growth
N/A
N/A
52 Week Low
$68.68
$211.43
52 Week High
$316.98
$343.12

Technical Indicators

Market Signals
Indicator
MNDY
BIO
Relative Strength Index (RSI) 37.81 42.45
Support Level $68.80 $266.71
Resistance Level $80.58 $289.61
Average True Range (ATR) 3.76 7.77
MACD 1.84 0.36
Stochastic Oscillator 46.51 29.77

Price Performance

Historical Comparison
MNDY
BIO

About MNDY monday.com Ltd.

Monday.com is a work management platform allowing for increased collaboration and visibility across an organization. Delivered via a SaaS-based model, users can track progress across marketing and development initiatives, create and automate workflows, and manage IT approvals. Revenue is generated on a per-seat basis across several pricing tiers. As of fiscal 2024, the company had over 245,000 customers.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: